Pharmaceutical stocks continued to rise in the afternoon, with LIVZON GROUP and nearly ten other stocks hitting the daily limit
In the afternoon, the pharmaceutical stocks continued to rise, with both innovative drugs and generic drugs performing well. Stocks such as LIVZON GROUP, MEDISAN, Qianhong Pharmaceutical, Wanbangde, Asia-Pacific Pharmaceutical, and ZHEJIANG ZHENYUAN hit the daily limit, while Guangshengtang, Laimei Pharmaceutical, and Wohu Biological rose over 10%. On the news front, the National Organization for Drug Procurement Office announced the selection of the 11th batch of centralized procurement varieties on the 15th. After three stages of screening, 55 varieties were included in the reporting scope of the 11th batch of centralized procurement. The procurement rules will generally adhere to the principles of "stabilizing clinical use, ensuring quality, preventing collusion, and countering internal competition."